Clinically-derived vagus nerve stimulation enhances cerebrospinal fluid penetrance

Volume: 13, Issue: 4, Pages: 1024 - 1030
Published: Jul 1, 2020
Abstract
IntroductionVagus nerve stimulation (VNS) is an FDA-approved neuromodulatory treatment used in the clinic today for epilepsy, depression, and cluster headaches. Moreover, evidence in the literature has led to a growing list of possible clinical indications, with several small clinical trials applying VNS to treat conditions ranging from neurodegenerative diseases to arthritis, anxiety disorders, and obesity. Despite the growing list of...
Paper Details
Title
Clinically-derived vagus nerve stimulation enhances cerebrospinal fluid penetrance
Published Date
Jul 1, 2020
Volume
13
Issue
4
Pages
1024 - 1030
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.